Amplification of Positivity for Alcohol Use
Part of paid clinical trials in Tulsa, Oklahoma.
- Sponsor
- Laureate Institute for Brain Research, Inc.
- Study ID
- NCT06030154
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Cognitive Behavioral Therapy — BEHAVIORALCognitive Behavioral Therapy
- Amplification of Positivity Therapy — BEHAVIORALAmplification of Positivity Therapy
- Surveys and Interviews — BEHAVIORALParticipants will answer questions regarding their mental and physical health as well as their substance use on the computer and in an interview format.
Study Details
The proposed study consists of two phases. During Phase 1, the investigators will recruit a small sample of participants to complete a psychosocial intervention termed Amplification of Positivity (AMP) for individuals experiencing comorbid depression or anxiety disorders and alcohol use disorder (AMP-A). These participants will be asked to provide both qualitative and quantitative input about the AMP-A intervention. Based on their input and clinician input, the AMP-A manual will be modified for use in Phase 2. The goal is to recruit up to 20 participants in order to ensure there will be at least 8 participants who complete all sessions of AMP-A. Phase 2 is a randomized clinical trial (RCT) protocol in which individuals experiencing comorbid depression or anxiety disorders and alcohol use disorder will be randomized to complete AMP-A or an evidence-based cognitive-behavioral therapy (CBT) intervention. Up to 100 participants will be recruited in order to reach a target of N=60. Assessed outcomes will include participant acceptability and completion rates, participant compliance with the intervention, positive and negative affect, substance use- and depression and anxiety-related symptom severity, functional disability, and neural reactivity to reward and alcohol cues during functional magnetic resonance imaging (fMRI).
Key Dates
- Start date
- Sep 25, 2023
- Status verified
- Jul 2025
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Amplification of Positivity TherapyAMP-A will involve 12, one-hour weekly therapy sessions completed one-on-one with a therapist. The sessions and between-session homework will focus on amplifying positive thoughts, emotions, and behaviors to address anxiety/depression and alcohol use.
- Active Comparator: Cognitive Behavioral TherapyThe CBT intervention will involve 12, one-hour weekly therapy sessions completed one-on-one with a therapist. The sessions and between-session homework will focus on monitoring of the relationship between thoughts, emotions, and alcohol use.
Primary Outcome Measure
Perceived acceptability and satisfaction of the intervention as measured with the Adherence and Acceptability Scale (AAS) [ Time Frame: Average of total scores from the following time points: pre-treatment, 2 weeks after starting treatment, 6 weeks after starting treatment, and at post-treatment (average of 16 weeks after baseline assessment) ]
Central Contacts
- Robin L Aupperle, PhD918-502-5155
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Laureate Institute for Brain Research | Tulsa | Oklahoma | 74008 |
Find similar trials in Tulsa, OK
Related Studies
- Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Outcome (AAC-BeT)Recruiting · Laureate Institute for Brain Research, Inc. · Tulsa, Oklahoma
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas
- IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric EDPHASE4 · Recruiting · University of Oklahoma · Oklahoma City, Oklahoma
- Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and DepressionPHASE4 · Recruiting · Laureate Institute for Brain Research, Inc. · Tulsa, Oklahoma